As of 04 Nov 2026 05:20 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2024/018 (12 Feb 2024): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Formoterol (Oxis® 6 Turbohaler) 6micrograms/dose dry powder inhalersaffected product · inferred from phrasing | Out of stock, as stated | mid March 2024precision: mid-month · window end 20 Mar 2024, derived from “mid March 2024” | notice of 12 Feb 2024 |
| Formoterol (Oxis® 12 Turbohaler) 12micrograms/dose dry powder inhalersnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 12 Feb 2024 |
| Alternative inhalersclass-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 12 Feb 2024 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Formoterol (Oxis® 12 Turbohaler) 12micrograms/dose dry powder inhalers — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Formoterol
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Sep 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 12 Feb 2024. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 12 Feb 2024 | Medicine Supply Notification: Formoterol (Oxis® 6 Turbohaler) 6micrograms/dose dry powder inhaler | Supply notification | Tier 2 | MSN/2024/018 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2026)28 Formoterol fumarate dihydrate (Atimos Modulite®) 12micrograms/dose inhaler · issued 28 Aug 2026 · valid until noted product is being discontinued, as stated · matched by name PDF ↗